Published on | 4 months ago
Programmes Agro-Food, EnvironmentCall HORIZON-CL6-2024-BIODIV-02_stage2 has closed on 17/09/2024.
21 proposals have been submitted.
The breakdown per topic is:
HORIZON-CL6-2024-BIODIV-02-1-two-stage: 6 proposals
HORIZON-CL6-2024-BIODIV-02-2-two-stage: 8 proposals
HORIZON-CL6-2024-BIODIV-02-3-two-stage: 7 proposals
Evaluation results are expected to be communicated in January 2025
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Digital, Industry & Space Cybersecurity Defence EDF
We hereby want you to give an overview of the known activities related to the EDF 2025 calls: Publication of the European Defence Fund (EDF) Work Programme 2025 infosessions: Belgian and Flanders EDF infoday on February 21st in Brussels The EDF Info Days 2025 will take place on 2-3 April in hybrid format in&n... read more
Digital, Industry & Space AI, data & cloud Deployment: Best use of technologies
The European Commission has published guidelines on prohibited artificial intelligence (AI) practices, as defined by the EU AI Act. The guidelines provide an overview of AI practices that are considered unacceptable due to their potential risks to European values and fundamental rights. The AI Act, which aims to promote innovation while... read more
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.